Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of nivolumab and ipilimumab in adults with HIV-associated relapsed or refractory classical Hodgkin lymphoma or metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Classical Hodgkin Lymphoma
• Kaposi Sarcoma
• Lung Cancer
• Solid Tumors
• Unresectable Solid Tumors

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Anal Carcinoma | Phase 1 | Status: TERMINATED | Results posted: 2025-09-23